These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24135170)

  • 1. Potential for inhibition of bacterial efflux pumps in multidrug-resistant Vibrio cholera.
    Varela MF; Kumar S; He G
    Indian J Med Res; 2013 Sep; 138(3):285-7. PubMed ID: 24135170
    [No Abstract]   [Full Text] [Related]  

  • 2. LysR family activator-regulated major facilitator superfamily transporters are involved in Vibrio cholerae antimicrobial compound resistance and intestinal colonisation.
    Chen S; Wang H; Katzianer DS; Zhong Z; Zhu J
    Int J Antimicrob Agents; 2013 Feb; 41(2):188-92. PubMed ID: 23201336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Na+-driven multidrug efflux pump VcmA from Vibrio cholerae non-O1, a non-halophilic bacterium.
    Huda MN; Morita Y; Kuroda T; Mizushima T; Tsuchiya T
    FEMS Microbiol Lett; 2001 Sep; 203(2):235-9. PubMed ID: 11583854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class 1 integrons and SXT elements conferring multidrug resistance in Vibrio cholerae O1 strains associated with a recent large cholera outbreak in Orissa, Eastern India.
    Jain M; Kumar P; Goel AK; Kamboj DV; Singh L
    Int J Antimicrob Agents; 2008 Nov; 32(5):459-60. PubMed ID: 18706789
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibiotic resistance mechanisms of Vibrio cholerae.
    Kitaoka M; Miyata ST; Unterweger D; Pukatzki S
    J Med Microbiol; 2011 Apr; 60(Pt 4):397-407. PubMed ID: 21252269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugated Linoleic Acid Reduces Cholera Toxin Production In Vitro and In Vivo by Inhibiting Vibrio cholerae ToxT Activity.
    Withey JH; Nag D; Plecha SC; Sinha R; Koley H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7471-6. PubMed ID: 26392502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of H- and D- MATE-type transporters from multidrug resistant clinical isolates of Vibrio fluvialis in conferring fluoroquinolone resistance.
    Mohanty P; Patel A; Kushwaha Bhardwaj A
    PLoS One; 2012; 7(4):e35752. PubMed ID: 22540001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholera outbreaks in Nigeria are associated with multidrug resistant atypical El Tor and non-O1/non-O139 Vibrio cholerae.
    Marin MA; Thompson CC; Freitas FS; Fonseca EL; Aboderin AO; Zailani SB; Quartey NK; Okeke IN; Vicente AC
    PLoS Negl Trop Dis; 2013; 7(2):e2049. PubMed ID: 23459673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer based screening for novel inhibitors against Vibrio cholerae using NCI diversity set-II: an alternative approach by targeting transcriptional activator ToxT.
    Mondal SI; Khadka B; Akter A; Roy PK; Sultana R
    Interdiscip Sci; 2014 Jun; 6(2):108-17. PubMed ID: 25172449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AlmG, responsible for polymyxin resistance in pandemic
    Henderson JC; Herrera CM; Trent MS
    J Biol Chem; 2017 Dec; 292(51):21205-21215. PubMed ID: 29101229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing characteristics of Vibrio cholerae: emergence of multidrug resistance and non-O1, non-O139 serogroups.
    Chandrasekhar MR; Krishna BV; Patil AB
    Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):1092-7. PubMed ID: 19062701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the multidrug efflux pump EmrD-3 from Vibrio cholerae by Allium sativum extract and the bioactive agent allyl sulfide plus synergistic enhancement of antimicrobial susceptibility by A. sativum extract.
    Bruns MM; Kakarla P; Floyd JT; Mukherjee MM; Ponce RC; Garcia JA; Ranaweera I; Sanford LM; Hernandez AJ; Willmon TM; Tolson GL; Varela MF
    Arch Microbiol; 2017 Oct; 199(8):1103-1112. PubMed ID: 28432381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Virulence of Toxigenic Vibrio cholerae by Anethole through the Cyclic AMP (cAMP)-cAMP Receptor Protein Signaling System.
    Zahid MS; Awasthi SP; Asakura M; Chatterjee S; Hinenoya A; Faruque SM; Yamasaki S
    PLoS One; 2015; 10(9):e0137529. PubMed ID: 26361388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence, Resistance, and Genomic Fingerprint Traits of
    Fu H; Yu P; Liang W; Kan B; Peng X; Chen L
    Microb Drug Resist; 2020 Dec; 26(12):1526-1539. PubMed ID: 33156741
    [No Abstract]   [Full Text] [Related]  

  • 15. Genomic plasticity associated with antimicrobial resistance in
    Verma J; Bag S; Saha B; Kumar P; Ghosh TS; Dayal M; Senapati T; Mehra S; Dey P; Desigamani A; Kumar D; Rana P; Kumar B; Maiti TK; Sharma NC; Bhadra RK; Mutreja A; Nair GB; Ramamurthy T; Das B
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6226-6231. PubMed ID: 30867296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural flavonoid morin showed anti-bacterial activity against Vibrio cholera after binding with cell division protein FtsA near ATP binding site.
    Nag D; Dastidar DG; Chakrabarti G
    Biochim Biophys Acta Gen Subj; 2021 Aug; 1865(8):129931. PubMed ID: 34023444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibacterial susceptibility/resistance of Vibrio cholerae eltor clinical strains isolated in the Caucasus during the seventh cholera pandemic].
    Savel'ev VN; Babenyshev BV; Savel'eva IV; Vasil'eva OV; Guseva LV; Grizhebovskiĭ GM; Kurbanov ShKh; Asvarov BM; Batyrova BA; Doroshenko IG; Antonenko AD
    Antibiot Khimioter; 2010; 55(5-6):8-13. PubMed ID: 21033468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India.
    Krishna BV; Patil AB; Chandrasekhar MR
    Trans R Soc Trop Med Hyg; 2006 Mar; 100(3):224-6. PubMed ID: 16246383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of Vibrio vulnificus RND efflux pumps homologous to Vibrio cholerae VexAB and VexCD, and to Escherichia coli AcrAB.
    Lee S; Yeom JH; Seo S; Lee M; Kim S; Bae J; Lee K; Hwang J
    J Microbiol; 2015 Apr; 53(4):256-61. PubMed ID: 25740377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Epidemiology and Antibiotic Susceptibility of Vibrio cholerae Associated with a Large Cholera Outbreak in Ghana in 2014.
    Eibach D; Herrera-León S; Gil H; Hogan B; Ehlkes L; Adjabeng M; Kreuels B; Nagel M; Opare D; Fobil JN; May J
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004751. PubMed ID: 27232338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.